CSIMarket
 
Alaunos Therapeutics Inc.  (TCRT)
Other Ticker:  
 
 


The company added good surprise for the investors, posting a significant rise in Mar 31 2022 report with operating loss of $-9.085 millions

Alaunos Therapeutics Inc. reported first quarter of 2022 operating loss of $-9.085 millions

Published 2022-05-19T05:04:11-04:00
Goran Soko / CSIMarket.com Contributer

pills_rapid_release_pills_By_Katy_Warner_from_Orlando_FL_USA_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons As the January to March 31 2022 reporting cycle goes on, countless entities have announced the respective earnings. Some of them, have been many corporations in the Major Pharmaceutical Preparations industry. And today, TCRT issued operating loss of $-9.085 millions, for the January to March 31 2022 interval.

Clearly the recent conduct as far as the managing day to day operations go, has dwarfed the same category in first quarter of 2021. Existing especially in the research span, it is one of the essential observation in this scenario.


In the financial first quarter of 2022 Alaunos Therapeutics Inc. reported net shortfall of $-9.788 million, instead of deficit of $-21.554 millions in the same reporting season a year ago.


Alaunos Therapeutics Inc. is expected to report next financial earnings on March 29, 2023.


    Recently Reported Results
pills_rapid_release_pills_By_Katy_Warner_from_Orlando_FL_USA_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons Global Blood Therapeutics Inc.

The company reported a fast Revenues increase , over the April to June 30 2022 time-frame

For the fiscal second quarter of 2022 Global Blood Therapeutics Inc. Losses have expanded of $-1.26 per share compare to $-1.12 a year prior and from $-1.26 per share from the preceding quarter.

Revenues rose strongly by 50.457 % to $71.55 millions from $47.56 millions in the similar quarter a year prior and sequentially Revenues improved by 29.714 % from $55.16 millions.


factory_night_long_exposure_industry_power_industrial_energy_global-589754 Industrial production

The output of the nation's factories, mines and utilities declined


Autosample_takes_a_By_Hey_Paul_(originally_posted_to_Flickr_as_image4)_[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons Pds Biotechnology Corp

Business expenses were increasing at the company in the second quarter of 2022

While the earnings season of the April to June 30 2022 period resumes, the most businesses have declared the respective results. Among them, have been multiple constituents of the Major Pharmaceutical Preparations sector. And now, Pds Biotechnology Corp issued operating shortfall of $-7.092652 millions, for the financial second quarter of 2022.


investment-2986344__340 Arya Sciences Acquisition Corp Iv

Business costs were on the rise at the Arya Sciences Acquisition Corp Iv in the fiscal span ending June 30 2022

Following the leaders in the Blank Checks sector, some smaller companies are impending with the respective earnings. ARYD mentioned it has clinched operating loss of $-0.304811 millions, for the second quarter of 2022.


20_Dollar_bills3_Source_selbstfotografiert_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons Northrim Bancorp Inc.

Very difficult fiscal period at Northrim Bancorp Inc. in the fiscal period closing Jun 30 2022

In the fiscal period closing Jun 30 2022 S&Ls Savings Banks company reported soft top and bottom-line, where EPS dropped by -37.59 % and revenue by -12.429 % year on year. Revenue were to $29.56 millions in proportion to $33.75 millions eps at $0.83 in proportion to $1.33 in the corresponding period a prior year.


Warehouse_By Cayco_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common Retail Inventories

March 2022 The inventories grew 2.9 %


workout_By_Nnu-12-22100541Tracy_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons Productivity

Productivity declined in first-quarter of 2022


Shopping_in_By_Ramunasjurevicius_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common Personal Income and Spending

Consumer spending on the rise again in June 2022

Consumer dipped into their savings to ramp up spending in June 2022, as spending increase outpaced growth in disposable income, according to the latest government data.

bank_interior_By_John_Bradley_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons Community Trust Bancorp Inc

Revenues regressed, at the company in the fiscal interval closing Jun 30 2022

For the April to June 30 2022 span company income fell by -14.93 % of $1.14 per share compare to $1.34 a year ago and income improved by 2.7 % from $1.11 per share from the preceding reporting season.

Revenues decreased by -7.646 % to $55.21 millions from $59.79 millions in the corresponding reporting season a year ago and sequentially Revenues increased by 2.018 % from $54.12 millions.


Acura_TL_trip_computer_pd Kandi Technologies Group Inc.

Demanding fiscal period for Kandi Technologies Group Inc. during the fiscal three months closing Jun 30 2022

Weak demand caused an increase in losses for the fiscal three months ending June 30 2022, company's net deficit per share inched up to $-0.02 from $0.54 where Revenue dropped by -30.241 % to $20.84 millions from $29.88 millions a year ago.


Counter_By_ARICA_(ARICAs file)__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common Modivcare Inc.

Modivcare Inc. declared epic results, in the financial interval ending June 30 2022

MODV announced earnings per share of $0.24 and Revenue of $574.94 millions in the financial interval ending June 30 2022, Modivcare Inc.s' earnings per share dived $0.24 per share, versus $0.96 eps, earned in the similar interval a year before, although the Personal Services company saw its Revenue rise by 32.873 % in the similar period.


science-2203701__340 Pacific Biosciences Of California Inc.

Excellent behavior by PACB over the second quarter of 2022 earnings season

For the fiscal second quarter of 2022 PACB Diminishing Returns have swelled of $-0.32 per share compare to $-0.21 a year prior and earnings per share improved from $-0.37 per share from the prior quarter.

Revenues inched up in double digits by 15.867 % to $35.47 millions from $30.61 millions in the comparable quarter a year prior and sequentially Revenues increased by 6.915 % from $33.17 millions.


Debit_Card_By_Elph_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons.jpg Green Dot Corp

due to Decrease in business

Lower turnover led to diminishing revenues and an increased shortfall, in the fiscal second quarter of 2022 GDOT reached break-even to $0.00 per share, while Revenue fell by -7.806 % to $362.77 millions, year on year.


World_Financial_Center_skyline2_pd Social Capital Hedosophia Holdings Corp. Vi

The emerging corporation from the Blank Checks sector the IPOF issued the fiscal span ending second quarter of 2022, numbers

Trailing the bellwethers in the Blank Checks sector, a number of smaller entities are coming in with the respective numbers. IPOF mentioned it has reported operating deficit of $-0.682275 millions, for the second quarter of 2022.




Other TCRT's Earnings Reports

Alaunos Therapeutics reported first quarter 2022 earnings

Alaunos Therapeutics reported third quarter 2021 earnings

Alaunos Therapeutics reported second quarter 2021 earnings

       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

TTEK's Profile

Stock Price

TTEK's Financials

Business Description

Fundamentals

Charts & Quotes

TTEK's News

Suppliers

TTEK's Competitors

Customers & Markets

Economic Indicators

TTEK's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071